Objective To analyze associations of gemcitabine-platinum chemotherapy effects with BRCA1 and RAP80 expressions in Ⅲ-IV non-small cell lung cancer( NSCLC). Methods The immunohistochemical method was used to detect expression of BRCA1 and RAP80 in 62 patients with Ⅲ-IV NSCLC. Chi ‐ square test was used to evaluate the association of chemotherapeutic effect with BRCA1 and RAP80 expressions. Spearman relationship was conducted to evaluate the associations among expression of BRCA1 and RAP80. Results In these 6...